All articles tagged: Type 2 diabetes mellitus without complications (E11.9)
![]()
HealthDay
01 July at 05.50 PM
American Diabetes Association, June 21-24The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest advances in di |
![]()
HealthDay
01 July at 03.33 PM
Few With Type 2 Diabetes Receive Guideline-Recommended CKD ScreeningFewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published online June 26 in JAMA Network Open.Daniel Edmonston, M.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues conducted a retrospective cohort study t |
![]()
HealthDay
28 June at 09.42 PM
Lower Cognitive Function in Adolescence Linked to Stroke RiskLower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the Journal of Epidemiology & Community Health.Aya Bardugo, M.D., from the Hebrew University in Jerusalem, and colleagues examined the association between adolescent cognitive function and |
![]()
HealthDay
27 June at 03.21 PM
ADA: Bisphenol A Linked to Reduced Peripheral Insulin SensitivityBisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.Adam Seal, Ph.D., from the California Polytechnic State University in San Luis Obispo, and collea |
![]()
HealthDay
27 June at 03.18 PM
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMDFor adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published online June 25 in JAMA Network Open.Simon Birk Kjær Jensen, Ph.D., from the University of Copenhagen in Denm |
![]()
HealthDay
27 June at 11.14 AM
Ignorance Could Be Fueling Rising Spread of STDs, Poll FindsMany sexually transmitted diseases are on the rise in the United States, and a nationwide poll indicates that ignorance about how they're transmitted could be fueling their spread.About a third of Americans (34%) falsely believe sexually transmitted infections (<a href="https://www.healthday.com/a-to-z-health/infectious-diseases/most-common-st |
![]()
HealthDay
26 June at 03.26 PM
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSATirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.At |
![]()
HealthDay
26 June at 03.25 PM
Dysbiosis in Phylogenetically Diverse Species Associated With Type 2 DiabetesThe gut microbiome has a potential functional role in the pathogenesis of type 2 diabetes (T2D), according to a study published online June 25 in Nature Medicine.Zhendong Mei, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues analyzed 8,117 shotgun metagenomes from 10 cohorts of individuals with T2D, prediabetes, and |
![]()
HealthDay
25 June at 03.03 PM
Semaglutide Cuts Incidence, Recurrence of Alcohol Use DisorderSemaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in Nature Communications.William Wang, from Case Western Reserve University in Cleveland, and colleagues used electronic health records of 83,825 patients with obesity to examine associa |
![]()
HealthDay
25 June at 03.01 PM
Intermittent Fasting Aids Early Diabetes Outcomes More Than DrugsIntermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or overweight, according to a study published online June 21 in JAMA Network Open.Lixin Guo, M.D., from the Chinese Academy of Medical Sciences in Beijing, and colleagues evaluated the effect of intermittent fasti |
![]()
HealthDay
21 June at 03.36 PM
Timing of Metformin Important in Metformin-Treated Type 2 DiabetesGlucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia.Cong Xie, Ph.D., from the University of Adelaide in Australia, and colleagues studied 16 participants with type 2 diabetes that was re |
![]()
HealthDay
20 June at 03.57 PM
Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer SurvivorsCancer survivors who identify as lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) have an increased burden of all chronic health conditions, disabilities, and limitations, according to a study published online June 20 in Cancer Epidemiology, Biomarkers & Prevention.Austin R. Waters, from the University of North Carolina a |
![]()
HealthDay
19 June at 03.43 PM
Benefits of Roux-en-Y Gastric Bypass Sustained in the Long TermRoux-en-Y gastric bypass (RYGB) is successful in achieving long-term sustained weight loss and diabetes remission, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.John Nguyen-Lee, M.D., from the Geisinger Medical Center in Danville, Pennsylva |
![]()
HealthDay
19 June at 12.01 PM
Deadly Strep Bacteria Is Spreading in JapanA deadly bacterial infection known as streptococcal toxic shock syndrome (STSS) is spreading across Japan, officials in that country report.In March, Japan's National Institute of Infectious Diseases issued its first warning&nbs |
![]()
HealthDay
18 June at 03.37 PM
Less Than One-Quarter of Patients Hospitalized for CVD Receive Dietary CounselingDietary counseling is infrequently documented after hospitalization for cardiovascular disease (CVD) episodes, according to a study recently published in the Journal of the Academy of Nutrition and Dietetics.Eric J. Brandt, M.D., from the University of Michigan in Ann Arbor, and colleagues used data from the Michigan Value Collabo |
![]()
HealthDay
17 June at 03.37 PM
Bariatric Surgery Cuts Conversion to Diabetes Over Long-Term Follow-UpBariatric surgery significantly decreases the conversion from prediabetes to type 2 diabetes, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.John Nguyen-Lee, M.D., from the Geisinger Medical Center in Danville, Pennsylvania, and colleagues eval |
![]()
HealthDay
13 June at 04.10 PM
GLP-1 RA Use Linked to Lower Quality of Bowel PreparationThe use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published online in the June issue of the American Journal of Gastroenterology.Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in R |
![]()
Evalytics
13 May at 08.50 PM
1 in 8 adults in the US has taken Ozempic or another GLP-1 drug, KFF survey findsThe article discusses a survey showing the rise in popularity of Ozempic, a GLP-1 drug, for type 2 diabetes. It highlights the drug's effectiveness and patient satisfaction, leading to increased prescriptions. However, concerns remain about its cost and accessibility for some patients. |
![]()
Evalytics
19 March at 06.08 AM
FDA approves first drug for common form of liver inflammationThe FDA has approved the first-ever medication for nonalcoholic steatohepatitis (NASH), a common form of liver inflammation linked to obesity, type 2 diabetes, and other metabolic conditions. NASH, characterized by liver inflammation due to excess fat accumulation, affects an estimated 6 to 8 million people in the US with moderate to advanced fibrosis. |
![]()
Evalytics
04 March at 06.12 PM
Eating Smart in a Processed World: The Truth About Ultra-Processed FoodsThe BMJ study by Lane MM et al. warns of health risks from ultra-processed foods like obesity and heart disease due to their poor nutrition. Global trends call for stricter regulations and healthier options. Both individuals and the food industry must act to promote healthier eating habits. |
![]()
Evalytics
04 March at 05.59 PM
Does yogurt reduce risk of diabetes? The FDA says it might.The FDA approves a claim linking yogurt consumption to reduced risk of type 2 diabetes, backed by scientific evidence. However, it underscores the importance of incorporating yogurt into a balanced diet and lifestyle for maximum health benefits. |
![]()
Evalytics
29 January at 05.19 PM
Why one particular diet is found to be the best year after yearThe Mediterranean diet is praised for its health benefits, reducing heart disease and promoting longevity. It emphasizes fresh fruits, vegetables, olive oil, and fish while limiting red meat and processed foods. Studies suggest it's an effective way to improve overall health. |
![]()
HealthDay
26 January at 10.07 PM
Coronary Artery Disease Testing After Initial Heart Failure Hospitalization Aids OutcomesCoronary artery disease (CAD) testing within 90 days of hospitalization for heart failure is associated with a lower risk for heart failure readmission or all-cause mortality, according to a study published online Jan. 18 in the Journal of General Internal Medicine.Cheng‑Wei Huang, M.D., from Kaiser Permanente Los Angeles Medical C |
![]()
HealthDay
23 January at 04.10 PM
Risks for Diabetes, CVD Up in Acute, Postacute COVID-19 PhasesThe risks for diabetes mellitus (DM) and cardiovascular disease (CVD) are increased in the acute and postacute COVID-19 phases, according to a study published online July 19 in PLOS Medicine.Emma Rezel-Potts, Ph.D., from King's College London, and colleagues conducted a cohort study from 2020 to 2021 analyzing electronic records for |
![]()
HealthDay
22 January at 04.59 PM
Healthful Plant-Based Diet May Lower Risk for Type 2 DiabetesA healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according to a study published in the January issue of Diabetes & Metabolism.Alysha S. Thompson, from Queen's University Belfast in Northern Ireland, and colleagues examined associations between healthful and unhealthful plant-based diet indices (hP |
![]()
HealthDay
17 January at 04.28 PM
Bariatric Surgery Tied to Slower Cognitive Decline in People With ObesityBariatric surgery may slow cognitive decline for people with obesity, according to a study published online Dec. 5 in the Journal of Nutrition, Health & Aging.Evan L. Reynolds, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined the effect of surgical weight loss on cognition in individuals with clas |
![]()
HealthDay
05 January at 10.20 PM
FDA Allows Florida to Import Cheaper Drugs From CanadaIn what could prove to be a major turning point for the prescription drug market in the United States, the U.S. Food and Drug Administration has approved a Florida plan to import drugs from Canada.U.S. residents can now buy directly from Canadian pharmacies out of their own pockets, but state Medicaid programs have not been allowed to purcha |
![]()
HealthDay
31 December at 04.59 AM
Catheter Ablation for Atrial Fibrillation Cuts Risk for Dementia, DeathIn patients with atrial fibrillation (AF), those undergoing catheter ablation have a lower risk for incident dementia and mortality, according to a study published online Aug. 23 in the Journal of the American Geriatrics Society.Stephanie L. Harrison, Ph.D., from the University of Liverpool in the United Kingdom, and colleagues examined |
![]()
HealthDay
29 December at 04.45 PM
High Levels of HDL Cholesterol Tied to Higher Dementia RiskElevated levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for all-cause dementia, according to a study published online Nov. 29 in The Lancet Regional Health: Western Pacific.Sultana Monira Hussain, M.B.B.S., M.P.H., Ph.D., from Monash University in Melbourne, Australia, and colleagues co |
![]()
HealthDay
28 December at 11.47 PM
Modifiable Risk Factors Tied to Young-Onset DementiaSeveral modifiable factors are associated with a higher risk for young-onset dementia (YOD), according to a study published online Dec. 26 in JAMA Neurology.Stevie Hendriks, Ph.D., from Maastricht University in the Netherlands, and colleagues examined 39 factors associated with the incidence of YOD from the literature using data |
![]()
HealthDay
26 December at 05.03 PM
KMgCit Superior to KCl for Preventing Thiazide-Induced HyperglycemiaFor patients with hypertension without diabetes, potassium magnesium citrate (KMgCit) is better than potassium chloride (KCl) for preventing thiazide diuretic (TD)-induced hyperglycemia, according to a study published in the December issue of Hypertension.Noting that TDs, which are the first-line treatment for hypertension, can cause e |
![]()
HealthDay
20 December at 05.12 PM
ED Visit Rate 72.2 Per 1,000 Adults With Diabetes in 2020 to 2021In 2020 to 2021, the emergency department visit rate was 72.2 visits per 1,000 adults with diabetes, with the rate increasing with age, according to a December data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.Loredana Santo, M.D., M.P.H., from the National Center for Health Stat |
![]()
HealthDay
13 December at 10.08 PM
New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss DrugsAccording to the latest University of Michigan National Poll on Healthy Aging, about three in four older Americans (76 percent) believe Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy, or Zepbound.More than four out of five older adults (83 percent) think insurance companies should pay for drugs that help people |
![]()
HealthDay
13 December at 03.42 PM
Perfluorooctanesulfonic Acid Exposure Linked to Lower Bone DensityIn a cohort of Hispanic adolescents and young adults, plasma perfluorooctanesulfonic acid (PFOS) exposure is associated with lower bone mineral density (BMD), according to a study published online Dec. 6 in Environmental Research.Emily Beglarian, M.P.H., from the Keck School of Medicine at the University of Southern California in Los |
![]()
HealthDay
11 December at 11.55 PM
High BMI in Adolescence Linked to Early CKD in Young AdulthoodHigh body mass index (BMI) in late adolescence is associated with early chronic kidney disease (CKD) in young adulthood, according to a study published online Dec. 11 in JAMA Pediatrics.Avishai M. Tsur, M.D., from the Israel Defense Forces, Medical Corps, in Ramat Gan, and colleagues examined the association between adolescent BMI and e |
![]()
Evalytics
11 December at 03.07 PM
New cause of diabetes discovered, offering potential target for new classes of drugs to treat the diseaseThe article discusses recent research on diabetes, indicating that there may be potential for new drug classes to treat the disease. Scientists are exploring innovative approaches to target different aspects of diabetes, potentially leading to more effective treatments in the future. |
![]()
HealthDay
07 December at 04.41 PM
Slow-to-Moderate Weight Loss Linked to Lower Mortality in Knee, Hip OAFor individuals with overweight or obesity and knee or hip osteoarthritis (OA), a slow-to-moderate, but not a fast, rate of weight loss is associated with a reduced risk for all-cause mortality, according to a study published online Dec. 6 in Arthritis & Rheumatology.Jie Wei, Ph.D., from Xiangya Hospital in Changsha, China, and col |
![]()
HealthDay
01 December at 04.56 PM
High Systolic BP Tied to Higher Cardiovascular Mortality in T2DMClinic systolic blood pressure (BP) ≥130 mm Hg or diastolic BP levels ≥90 mm Hg are associated with a higher risk for cardiovascular disease (CVD) mortality in people with type 2 diabetes mellitus (T2DM), according to a study published online Nov. 28 in the Journal of the American Heart Association.Loraine Liping Seng, Ph.D., from t |
![]()
HealthDay
29 November at 04.42 PM
Walking at Faster Speeds Linked to Reduction in Risk for Type 2 DiabetesWalking at faster speeds seems to be associated with a reduction in the risk for type 2 diabetes, according to a review published online Nov. 28 in the British Journal of Sports Medicine.Ahmad Jayedi, Ph.D., from the University of Medical Sciences in Semnan, Iran, and colleagues examined the association between walking speed and the |
![]()
HealthDay
28 November at 04.38 PM
Study IDs Barriers to Eye Screening Among Adults With DiabetesFood insecurity, housing insecurity, mental health concerns, and the perceived importance of practitioner concordance are associated with a lower likelihood of receiving eye care among adults with diabetes, according to a study published online Nov. 16 in JAMA Ophthalmology.Rohith Ravindranath, from Stanford University in Palo Alt |
![]()
HealthDay
27 November at 04.51 PM
American Heart Association, Nov. 11-13The annual meeting of the American Heart Association was held this year from Nov. 11 to 13 in Philadelphia and attracted participants from around the world, including cardiovascular specialists, surgeons, and nurses as well as other health care professionals. The conference featured presentations focusing on the lates |
![]()
HealthDay
22 November at 04.33 PM
Mean Platelet Volume Linked to Mortality in Peritoneal Dialysis PatientsFor patients treated with peritoneal dialysis (PD), mean platelet volume (MPV) is associated with all-cause mortality and cardiovascular mortality, according to a study published online Nov. 8 in BMC Cardiovascular Disorders.Jianghai Wang, from the Dongying People's Hospital in China, and colleagues estimated the relationship between |
![]()
HealthDay
14 November at 11.43 PM
American Society of Nephrology, Nov 2-5The annual meeting of the American Society of Nephrology (Kidney Week) was held this year from Nov. 2 to 5 in Philadelphia and attracted participants from around the world, including nephrology specialists, researchers, scientists, and other health care professionals. The conference featured presentations focusing on the latest adv |
![]()
HealthDay
09 November at 04.08 PM
FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med MounjaroA second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro.Zepbound works by activating hormone receptors in the body to reduce appetite |
![]()
Evalytics
06 November at 03.44 PM
Another Study Ties Statins to T2D: Should Practice Change?A recent study from the LODESTAR trial suggests a modestly increased risk of type 2 diabetes with statin use, particularly with rosuvastatin over atorvastatin. Despite this, the cardiovascular benefits of statins are deemed to outweigh the diabetes risk, with experts advocating for their continued use while calling for more research into managing the associated diabetes risk. |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |